KKR, TPG to exit Zimmer Biomet in $965 mln secondary
Zimmer Biomet Holdings Inc said Aug 10 that two of its stockholders, KKR and TPG Capital, are selling roughly 7.4 million shares in a secondary offering. The shares are being sold to the public at an initial price of $129.75 per share. The selling stockholders will receive all the proceeds, about $965.4 million, from the sale. Nothing will go to Zimmer Biomet or any of its directors. Goldman, Sachs & Co and J.P. Morgan are acting as joint book-running managers for the sale.
10 August 2016•4 mins read
